Notice: Prescription Drug List (PDL): Naloxone

The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis : Liste des drogues sur ordonnance (LDO) : Naloxone
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "Naloxone"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "Naloxone"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source